Metabolism of protein-bound DOPA in mammals

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 9, 2000, Pages 945-955

  Rodgers, Kenneth J ^a   Dean, Roger T ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

3,4 dihydroxyphenylalanine (DOPA); Oxidation; Oxychelate; Proteolysis; Radical

Indexed keywords

AMINO ACID; CHELATE; DNA; DOPA; LOW DENSITY LIPOPROTEIN; METAL ION; PLASMA PROTEIN; RADICAL; TYROSINE 3 MONOOXYGENASE;

ATHEROSCLEROSIS; CATARACT; CHELATION; CROSS LINKING; DETOXIFICATION; HUMAN; MAMMAL; NONHUMAN; PHOTOLYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; REVIEW; URINARY EXCRETION;

MAMMALIA;

EID: 0033732222     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00034-0     Document Type: Short Survey

References (63)

1. Melanin
2. Chemical characterization of eumelanins with special emphasis on 5,6-dihdroxyindole-2-carboxylic acid content and molecular size
3. Chemical characterization of pheomelanogenesis starting from dihydroxyphenylalanine or tyrosine and cysteine. Effects of tyrosinase and cysteine concentrations reaction time
4. Relationship between melanin content and superoxide dismutase (SOD) activity in the liver of various species of animals
5. Radicals in melanin biochemistry
6. Novel free radicals in synthetic and natural pheomelanins: Distinction between dopa melanins and cysteinyldopa melanins by ESR spectroscopy
7. The phylogeny and chemical diversity of quinone-tanned glues and varnishes
8. Aromatic cross-links in insect cuticle: Detection by solid-state 13C and 15N NMR
9. Interaction of melanosomal proteins with melanin
10. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues
11. Tyrosine formation from phenylalanine by ultraviolet irradiation
12. Radiation induced formation of dihydroxyphenylalanine from tyrosine and tyrosine-containing peptdies in aqueous solution
13. Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins
14. The hydroxyl radical in lens nuclear cataractogenesis
15. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque
16. Quinoenzymes in biology
17. DNA damage and selective toxicity of dopa and ascorbate: Copper in human melanoma cells
18. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells
19. Neuronal source of plasma dihydroxyphenylalanine
20. Evidence for a repeating 3,4-dihydroxyphenylalanine- and hydroxyproline-containing decapeptide in the adhesive protein of the mussel, Mytilus edulis L
21. Hydroxyarginine-containing polyphenolic proteins in the adhesive plaque of the marine mussel Mytilus edulis
22. Structure and mucoadheshion of mussel glue protein in dilute solution
23. Vanadium in ascidians and the chemistry of tunichromes
24. Long-lived reactive species on free-radical-damaged proteins
25. Transition metals bind to glycated proteins forming redox active 'glycochelates': Implications for the pathogenesis of certain diabetic complications
26. The protein oxidation product 3,4-dihydroxyphenylalanine (DOPA) mediates oxidative DNA damage
27. Radiation-induced formation of 3,4-dihydrxyphenylalanine in tyrosine- containing peptides and proteins as a function of X-irradation dose
28. Formation of protein-bound 3,4-dihydroxyphenylalanine in collagen types I and IV exposed to ultraviolet light
29. Ionization theory and radio-biological reactions
30. Note on the oxidation of tyrosine, tyramine and phenylalanine with hydrogen peroxide
31. Photooxidation of phenol, cresols, and dihydroxybenzenes
32. Tyrosine modification by reactive nitrogen species: A closer look
33. The great DOPA mystery: The source and significance of DOPA in phase I melanogenesis
34. Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-3,4-dihydroxyphenylalanine
35. Elucidating the rate limiting step in norepinephrine biosynthesis in perfused guinea-pig heart,
36. Source and physiological significance of plasma 3,4-dihydroxyphenylalanine in the rat
37. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans
38. Dopa and 5-S-cysteinyIdopa in the serum of albino, black, and red guinea pigs
39. Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase
40. Skin color, aging, and plasma L-DOPA levels
41. Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man
42. Transfer mechanism of melanosomes in epidermal cell culture
43. Naevogenesis: A hypothesis concerning the control of proliferation of melanocytes with special reference to the growth of intradermal naevi
44. Human ocular melanocytes and retinal pigment epithelial cells differ in their melanogenic properties in vivo and in vitro
45. The pathogenesis of melannoma induced by ultraviolet radiation
46. Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound DOPA and 5-S-cysteinyIDOPA
47. Human apo-lipoprotein B from normal plasma contains oxidised peptides
48. The biochemistry and pathology of radical-mediated protein oxidation
49. Inefficient degradation of oxidized regions of protein molecules
50. Tyrosinase-catalyzed binding of 3,4-dihydroxyphenylalanine with proteins through the sulfhydryl group
51. 5-S-cysteinyIDOPAC in human urine
52. 5 years' experience of 5-S-cysteinyIdopa in melanoma diagnosis
53. Urinary free and conjugated 5-S-cysteinyIdopa in normal subjects and in patients with melanoma
54. Dopa and 5-S-cysteinyIDOPA in the urine in healthy humans
55. 5 years' experience of 5-S-cysteinyIDOPA in melanoma diagnosis
56. Urinary excretion of 5-S-cysteinyIdopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid: Differences between pigmented and albino mice
57. Melanocyte metabolites in the urine of people of different skin colour
58. Melanin-related metabolites as markers of the skin pigmentary system
59. Plasma 5-S-cysteinyIDOPA concentrations in oculocutaneous
60. Plasma 5-S-cysteinyIDOPA as an index of melanogenesis
61. Formation of cysteinyIdopa from glutathionedopa in melanoma